Fumiko Mori

1.4k citations

29 papers · 570 indexed · h-index 14

Impact in

Immunology top 10%
- T-cell and Retrovirus Studies
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Agronomy and Crop Science top 10%
- Animal Disease Management and Epidemiology

Papers in

Immunology 12
- T-cell and Retrovirus Studies 8
- Immune Cell Function and Interaction 6
Oncology 11
- CAR-T cell therapy research 6

Co-authors: Takashi Ishida Asahi Ito Ryuzo Ueda Shigeru Kusumoto Shinsuke Iida Hirokazu Komatsu Masaki Ri Hiroshi Inagaki
Journals: Blood (8 papers)International Journal of Hematology (3 papers)The Journal of Immunology (3 papers)Cancer Immunology Immunotherapy (2 papers)Cancer Science (2 papers)
Partner nations: Japan United States

In The Last Decade

Fumiko Mori

29 papers receiving 554 citations

Peers

Countries citing papers authored by Fumiko Mori

Since Specialization

Citations

This map shows the geographic impact of Fumiko Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumiko Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumiko Mori more than expected).

Fields of papers citing papers by Fumiko Mori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumiko Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumiko Mori. The network helps show where Fumiko Mori may publish in the future.

Co-authors

The 25 scholars most cited alongside Fumiko Mori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fumiko Mori Line = papers co-authored together Fumiko Mori links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Newly diagnosed follicular lymphoma during pembrolizumab treatment for lung cancer International Journal of Hematology ·LALA SEYIDZADE, Shigeru Kusumoto, Ayako Masaki, Takahiro Nakashima, Yury Dinency, Fumiko Mori, Hirokazu Komatsu, Hiroshi Inagaki, Shinsuke Iida, Atsushi Inagaki	2021	2
2	Effectiveness of Avoiding HDMs for Managing Childhood Asthma Nihon Kikan Shokudoka Gakkai Kaiho ·Jalbtcx, Akiko Sano, Clemens Kuby, Hiroyuki Sano, Fumiko Mori, Yuji Tohda	2018	1
3	CD30-positive primary bone marrow lymphoma mimicking Hodgkin lymphoma International Journal of Hematology ·Tomotaka Suzuki, Shigeru Kusumoto, Ayako Masaki, Takashi Ishida, Hiroshi Inagaki, Shinsuke Iida, Fumiko Mori	2014	2
4	Amelanotic Malignant Melanoma of Unknown Primary Origin Metastasizing to the Bone Marrow: A Case Report and Review of the Literature Internal Medicine ·Tomotaka Suzuki, Shigeru Kusumoto, Shinsuke Iida, Toyohiro Tada, Fumiko Mori	2014	8
5	Antitumor effects of bevacizumab in a microenvironment‐dependent human adult T‐cell leukemia/lymphoma mouse model European Journal Of Haematology ·Fumiko Mori, Takashi Ishida, Asahi Ito, Fumihiko Sato, Ayako Masaki, Tomoko Narita, Susumu Suzuki, Tomiko Yamada, Hisashi Takino, Masaki Ri, Shigeru Kusumoto, Hirokazu Komatsu, Masakatsu Hishizawa, Kazunori Imada, Akifumi Takaori‐Kondo, Akio Niimi, Ryuzo Ueda, Hiroshi Inagaki, Shinsuke Iida	2013	5
6	HTLV-1 bZIP Factor–Specific CD4 T Cell Responses in Adult T Cell Leukemia/Lymphoma Patients after Allogeneic Hematopoietic Stem Cell Transplantation The Journal of Immunology ·Tomoko Narita, Takashi Ishida, Ayako Masaki, Susumu Suzuki, Asahi Ito, Fumiko Mori, Tomiko Yamada, Masaki Ri, Shigeru Kusumoto, Hirokazu Komatsu, Yasuhiko Miyazaki, Y Takatsuka, Atae Utsunomiya, Akio Niimi, Shinsuke Iida, Ryuzo Ueda	2013	14
7	Tax is a potential molecular target for immunotherapy of adult T‐cell leukemia/lymphoma Cancer Science ·Susumu Suzuki, Ayako Masaki, Takashi Ishida, Asahi Ito, Fumiko Mori, Fumihiko Sato, Tomoko Narita, Masaki Ri, Shigeru Kusumoto, Hirokazu Komatsu, Yasuo Fukumori, Hiroyoshi Nishikawa, Yuetsu Tanaka, Akio Niimi, Hiroshi Inagaki, Shinsuke Iida, Ryuzo Ueda	2012	18
8	Angioimmunoblastic T-cell lymphoma mice model Leukemia Research ·Fumihiko Sato, Takashi Ishida, Asahi Ito, Fumiko Mori, Ayako Masaki, Hisashi Takino, Tomoko Narita, Masaki Ri, Shigeru Kusumoto, Susumu Suzuki, Hirokazu Komatsu, Akio Niimi, Ryuzo Ueda, Hiroshi Inagaki, Shinsuke Iida	2012	13
9	Reduced Expression of HDAC3 Contributes to the Resistance Against HDAC Inhibitor, Vorinostat (SAHA) in Mature Lymphoid Malignancies Blood ·고소정, Masaki Ri, Tomoko Narita, Ayako Masaki, Fumiko Mori, Asahi Ito, Shigeru Kusumoto, Takashi Ishida, Hirokazu Komatsu, Yukimasa Shiotsu, Akio Niimi, Shinsuke Iida	2012	3
10	Identification of Toyocamycin, an Agent Cytotoxic for Multiple Myeloma Cells, As a Potent Inhibitor of ER Stress-Induced XBP1 mRNA Splicing Blood ·Masaki Ri, Etsu Tashiro, Daisuke Oikawa, Satoko Shinjo, Mio Tokuda, John Hawkins, Tomoko Narita, Ayako Masaki, Fumiko Mori, Asahi Ito, 고소정, Shigeru Kusumoto, Takashi Ishida, Hirokazu Komatsu, Yukimasa Shiotsu, Akio Niimi, Ryuzo Ueda, Takao Iwawaki, Masaya Imoto, Shinsuke Iida	2012	6
11	Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma: two case reports International Journal of Hematology ·Tatsuya Yoshida, Shigeru Kusumoto, Atsushi Inagaki, Fumiko Mori, Asahi Ito, Masaki Ri, Takashi Ishida, Hirokazu Komatsu, Shinsuke Iida, Fuminaka Sugauchi, Yasuhito Tanaka, Masashi Mizokami, Ryuzo Ueda	2010	15
12	A complement-dependent cytotoxicity-enhancing anti-CD20 antibody mediating potent antitumor activity in the humanized NOD/Shi-scid, IL-2Rγnull mouse lymphoma model Cancer Immunology Immunotherapy ·Fumihiko Sato, Asahi Ito, Takashi Ishida, Fumiko Mori, Hisashi Takino, Atsushi Inagaki, Masaki Ri, Shigeru Kusumoto, Hirokazu Komatsu, Shinsuke Iida, Noriko Okada, Hiroshi Inagaki, Ryuzo Ueda	2010	13
13	Expression of the ULBP ligands for NKG2D by B‐NHL cells plays an important role in determining their susceptibility to rituximab‐induced ADCC International Journal of Cancer ·Atsushi Inagaki, Takashi Ishida, Hiroki Yano, Toshihiko Ishii, Shigeru Kusumoto, Asahi Ito, Masaki Ri, Fumiko Mori, Jianmin Ding, Hirokazu Komatsu, Shinsuke Iida, Ryuzo Ueda	2009	27
14	The Asn505 mutation of the c-MPL gene, which causes familial essential thrombocythemia, induces autonomous homodimerization of the c-Mpl protein due to strong amino acid polarity Blood ·Jianmin Ding, Hirokazu Komatsu, Shinsuke Iida, Hiroki Yano, Shigeru Kusumoto, Atsushi Inagaki, Fumiko Mori, Masaki Ri, Asahi Ito, Atsushi Wakita, Takashi Ishida, Masakazu Nitta, Ryuzo Ueda	2009	45
15	Defucosylated Anti-CCR4 Monoclonal Antibody Exerts Potent ADCC against Primary ATLL Cells Mediated by Autologous Human Immune Cells in NOD/Shi-scid, IL-2Rγnull Mice In Vivo The Journal of Immunology ·Asahi Ito, Takashi Ishida, Atae Utsunomiya, Fumihiko Sato, Fumiko Mori, Hiroki Yano, Atsushi Inagaki, Susumu Suzuki, Hisashi Takino, Masaki Ri, Shigeru Kusumoto, Hirokazu Komatsu, Shinsuke Iida, Hiroshi Inagaki, Ryuzo Ueda	2009	55
16	Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rγnull mouse model Cancer Immunology Immunotherapy ·Asahi Ito, Takashi Ishida, Hiroki Yano, Atsushi Inagaki, Susumu Suzuki, Fumihiko Sato, Hisashi Takino, Fumiko Mori, Masaki Ri, Shigeru Kusumoto, Hirokazu Komatsu, Shinsuke Iida, Hiroshi Inagaki, Ryuzo Ueda	2008	96
17	Overexpression of carboxylesterase‐2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT‐11), for multiple myeloma Cancer Science ·Hiroki Yano, A. Dumusc, Shinsuke Iida, Zizhi Mo, Tetsuya Oguri, Takaomi Sanda, 고소정, Fumiko Mori, Asahi Ito, Masaki Ri, Atsushi Inagaki, Shigeru Kusumoto, Takashi Ishida, Hirokazu Komatsu, Hiroshi Inagaki, Atsushi Suzuki, Ryuzo Ueda	2008	35
18	Effect of “xylophone therapy” for a patient of unilateral spatial neglect. Shinichi Noto, Fumiko Mori, Kazu Amimoto, Satoshi Sugimoto, Md. Safayat Husnain	1999	2
19	Structure and transcription of the tRNA₁^Progene fromEscherichia coli Nucleic Acids Research ·Yoshiyuki Kuchino, Fumiko Mori, Susumu Nishimura	1985	17
20	Nucleotide sequences of three proline tRNAs fromSalmonella typhimurium Nucleic Acids Research ·Yoshiyuki Kuchino, 善雄梅野, Fumiko Mori, JA Laird	1984	27

About Fumiko Mori

Fumiko Mori is a scholar working on Immunology, Oncology, Pathology and Forensic Medicine, Hematology and Agronomy and Crop Science, having authored 29 papers that have together received 570 indexed citations. Recurring topics across this work include T-cell and Retrovirus Studies (8 papers), Lymphoma Diagnosis and Treatment (7 papers), CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (6 papers), Vector-Borne Animal Diseases (5 papers), Chronic Lymphocytic Leukemia Research (3 papers), Animal Disease Management and Epidemiology (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Immunology (265 citations), Agronomy and Crop Science (57 citations), Oncology (153 citations), Genetics (59 citations) and Hematology (51 citations). Fumiko Mori has collaborated with scholars based in Japan and United States. Frequent co-authors include Takashi Ishida, Asahi Ito, Ryuzo Ueda, Shigeru Kusumoto, Shinsuke Iida, Hirokazu Komatsu, Masaki Ri, Hiroshi Inagaki, Atsushi Inagaki and Hiroki Yano. Their work appears in journals such as Blood, International Journal of Hematology, The Journal of Immunology, Cancer Immunology Immunotherapy and Cancer Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact